Kimberly Jacobson/LinkedIn
Aug 25, 2026, 11:54
Kimberly Jacobson: MSL Opportunity in Rare Blood and Bleeding Disorders
Kimberly Jacobson, Director of Medical Science Liaisons at Sanofi, shared a post on LinkedIn:
“I am excited to share that we have an open Medical Science Liaison position on our Rare Blood Disorders team at Sanofi, covering the upper Midwest territory!
We are a passionate, high-performing team deeply committed to making a meaningful difference for patients and families living with hemophilia — and we are looking for someone who shares that same drive.
If you have MSL experience or a clinical background in hemophilia and are ready to bring your scientific expertise to a field-facing role where you can truly impact patient care, I would love to connect!”
Stay updated with Hemostasis Today.
-
Oct 12, 2026, 13:58Francisco Chacón-Lozsán: Catastrophic Antiphospholipid Syndrome A Rapidly Progressive Multiorgan Thrombotic Emergency
-
Oct 12, 2026, 12:50Nawsherwan Mohammad: Study Examines Thrombotic Events in Patients with Polycythemia Vera in Iraq
-
Oct 12, 2026, 12:30Chanakya Nayudu: Looking Beyond Blood Clots – Patient-Reported Outcomes in Antiphospholipid Syndrome
-
Oct 12, 2026, 12:12Jean-Jacques Kiladjian: Improving Treatment Strategies with JAK Inhibitors in Myelofibrosis
-
Oct 12, 2026, 12:04Chloe Homich: AABB Annual Meetings – Building Connections and Advancing Transfusion Medicine
-
Oct 12, 2026, 11:51Daniel Sop: Sickle Cell Research Takes Center Stage at ASCAT 2026
-
Oct 12, 2026, 10:36PAI-1 Inhibition as a New Strategy for Enhancing Fibrinolysis and Clot Resolution
-
Oct 12, 2026, 07:39Emmanuel J Favaloro: 100 Years of von Willebrand Disease and the Importance of Local Diagnosis and Management
-
Oct 12, 2026, 07:39Post-Stroke Fatigue Trajectories – 38% Recovered at 12 Months, While 16% Developed New Fatigue – International Journal of Stroke